Web Sify
Follow us on
Sify.com » Topics » Glenmark Pharma
Glenmark Pharma News

Glenmark close to final clinical trials for asthma, arthritis drugs
Glenmark Pharmaceuticals is set to enter the final stage of clinical trials for its new drug, Revamilast, across several countries this year. It is meant for treatment of inflammatory disorders like asthma and rheumatoid arthritis. Glenmark may soon seek approval for Phase-III trials in the US, UK and India. “Glenmark plans to file an IND (Investigational New Drug application) for Revamilast
Glenmark Pharma Galleries